For cancer patients, medicines administered in clinical trials can help save or extend lives. But despite thousands of trials in the United States each year, only 3% to 5% of eligible patients enroll in investigations of new treatments. Triomics, a generative AI startup, claims it can significantly...
Read Also
- Record low Antarctic sea ice 'extremely unlikely' without climate change, says scientists
- Study finds evidence that subduction zone splay faults compound hazards of great earthquakes
- Liam Hemsworth’s Geralt of Rivera Finally Revealed
- Our favorite Anker wireless earbuds are back on sale for $50
- Meta and LG’s headset partnership is on the rocks
- Unbuilt data centers in high demand as firms secure space years in advance
- NYT Mini Crossword today: puzzle answers for Monday, May 20
- Everything you need to know about Only Murders in the Building season 4
- NYT Connections: hints and answers for Monday, May 20
- NYT Strands today: hints, spangram and answers for Monday, May 20
Latest TechCrunch
- CyberArk snaps up Venafi for $1.54B to ramp up in machine-to-machine security
- OpenseedVC, which backs operators in Africa and Europe starting their companies, reaches first close of $10M fund
- Pine Labs gets Singapore court approval to shift base to India
- UK opens office in San Francisco to tackle AI risk
- Why companies are turning to internal hackathons
- I’m rooting for Melinda French Gates to fix tech’s broken ‘brilliant jerk’ culture
- Blue Origin successfully launches its first crewed mission since 2022
- Hollywood agency CAA aims to help stars manage their own AI likenesses
- Expedia says two execs dismissed after ‘violation of company policy’
- OpenAI and Google lay out their competing AI visions